Literature DB >> 21833477

Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.

Kunio Yoshizawa1, Shinichi Nozaki, Hiroko Kitahara, Koroku Kato, Natsuyo Noguchi, Shuichi Kawashiri, Etsuhide Yamamoto.   

Abstract

It is well documented that the binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR), which has been implicated in cancer invasion and metastasis, is regulated by several inhibitors such as maspin. In this study, we investigated the interrelationship between clinicopathologic findings and expression of uPA, uPAR and maspin in oral squamous cell carcinoma (OSCC) to elucidate the participation of maspin in the uPA/uPAR system in the malignant behavior of OSCC. Using immunohistochemical techniques to examine the expression levels of uPA, uPAR and maspin in 54 cases of OSCC, we also compared the clinicopathologic features of OSCC with the expression levels of each. Moreover, we examined the expression of uPA, uPAR and maspin in six cell lines derived from OSCC using reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting. uPA and uPAR showed a positive correlation with the mode of cancer invasion; conversely maspin showed a negative correlation with the mode of invasion. Multivariate analysis revealed that only two factors (N-category and uPA+/uPAR+/maspin- expression pattern) were significant and independent variables with relative risks of 3.84 and 2.52, respectively. In particular, tumors exhibiting an expression pattern of uPA+/uPAR+/maspin- were highly malignant and were associated with the worst survival rate (5-year overall survival rate, 29.4%), while tumors with an expression pattern, uPA-/uPAR-/Μaspin+, showed the most favorable survival rate (5-year overall survival rate, 77.8%). In vitro, lower expression of maspin was also noted in the cell lines derived from grade 4D OSCC, which exhibited a stronger invasive potential than the cells lines derived from the other grades of OSCC, while uPA and uPAR demonstrated an expression trend opposite to maspin. These results indicate that uPA, uPAR and maspin expression patterns may be useful markers for evaluating the clinical course or prognosis of OSCC patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833477     DOI: 10.3892/or.2011.1419

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety.

Authors:  Sadaf Vahdat; Seyed Ahmad Mousavi; Gholamreza Omrani; Maziar Gholampour; Fattah Sotoodehnejadnematalahi; Zaniar Ghazizadeh; Javad Gharechahi; Hossein Baharvand; Ghasem Hosseini Salekdeh; Nasser Aghdami
Journal:  Stem Cells Dev       Date:  2015-06-15       Impact factor: 3.272

2.  Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis.

Authors:  Zhiqiang Liu; Yangyang Shi; Wei Meng; Yufang Liu; Kaixuan Yang; Shuhua Wu; Zhilan Peng
Journal:  Arch Gynecol Obstet       Date:  2014-02       Impact factor: 2.344

3.  Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells.

Authors:  Liang Xu; Hongyuan Liu; Ju Yu; Zhongyong Wang; Qing Zhu; Zongping Li; Qi Zhong; Shuyu Zhang; Mingqi Qu; Qing Lan
Journal:  Oncol Rep       Date:  2016-05-04       Impact factor: 3.906

4.  The Iron Chelator, Dp44mT, Effectively Inhibits Human Oral Squamous Cell Carcinoma Cell Growth in Vitro and in Vivo.

Authors:  Jehn-Chuan Lee; Kun-Chun Chiang; Tsui-Hsia Feng; Yu-Jen Chen; Sung-Ting Chuang; Ke-Hung Tsui; Li-Chuan Chung; Horng-Heng Juang
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

5.  Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.

Authors:  Anders Christensen; Katalin Kiss; Giedrius Lelkaitis; Karina Juhl; Morten Persson; Birgitte Wittenborg Charabi; Jann Mortensen; Julie Lyng Forman; Anne Lyngholm Sørensen; David Hebbelstrup Jensen; Andreas Kjaer; Christian von Buchwald
Journal:  BMC Cancer       Date:  2017-08-25       Impact factor: 4.430

Review 6.  Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.

Authors:  Maria Noel Marzano Rodrigues Petruzzi; Karen Cherubini; Fernanda Gonçalves Salum; Maria Antonia Zancanaro de Figueiredo
Journal:  Diagn Pathol       Date:  2017-04-05       Impact factor: 2.644

7.  Role of maspin in cancer.

Authors:  Rossana Berardi; Francesca Morgese; Azzurra Onofri; Paola Mazzanti; Mirco Pistelli; Zelmira Ballatore; Agnese Savini; Mariagrazia De Lisa; Miriam Caramanti; Silvia Rinaldi; Silvia Pagliaretta; Matteo Santoni; Chiara Pierantoni; Stefano Cascinu
Journal:  Clin Transl Med       Date:  2013-03-07

8.  Cytokines and tumor metastasis gene variants in oral cancer and precancer in Puerto Rico.

Authors:  Esther Erdei; Li Luo; Huiping Sheng; Erika Maestas; Kirsten A M White; Amanda Mackey; Yan Dong; Marianne Berwick; Douglas E Morse
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

9.  Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC).

Authors:  Synnøve Magnussen; Oddveig G Rikardsen; Elin Hadler-Olsen; Lars Uhlin-Hansen; Sonja E Steigen; Gunbjørg Svineng
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

Review 10.  uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.

Authors:  Miguel Angel Pavón; Irene Arroyo-Solera; Maria Virtudes Céspedes; Isolda Casanova; Xavier León; Ramón Mangues
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.